🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Zhejiang Xianju Pharmaceutical Co., Ltd. (SHE:002332)
China flag China · Delayed Price · Currency is CNY
8.32
-0.16 (-1.89%)
Nov 20, 2026, 3:04 PM CST

SHE:002332 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
3,8333,7313,9804,0794,3584,335
Other Revenue
28.4328.4321.1743.9621.5222.46
3,8623,7594,0014,1234,3804,357
Revenue Growth
7.59%-6.04%-2.98%-5.85%0.52%8.42%
Cost of Revenue
1,5521,4971,7441,9721,8651,848
Gross Profit
2,3102,2622,2562,1522,5152,509
Selling, General & Admin
1,5391,4981,3441,2711,5321,560
Research & Development
280.9303.75265.17261266.77243.37
Other Operating Expenses
34.3226.1319.2622.0432.9232.73
Operating Expenses
1,8571,8331,6391,5471,8361,836
Operating Income
453.2428.98617.42604.79678.81672.92
Interest Expense
-4.02-4.64-3.13-3.37-6.29-23.1
Interest & Investment Income
13.7216.7329.4838.2876.5443.19
Currency Exchange Gain (Loss)
-2.98-2.9810.57-9.3211.817.44
Other Non Operating Income (Expenses)
-6.98-3.53-2.7-5.53-11.25-5.26
EBT Excluding Unusual Items
452.93434.55651.63624.85749.6705.19
Gain (Loss) on Sale of Investments
-28.71-26.41-8.14-8.97-00.64
Gain (Loss) on Sale of Assets
-3.4446.30.28-1.4891.6214.51
Asset Writedown
-9.22-1.76-1.31-0.42-0.91-1.68
Other Unusual Items
98.8210.64-170.8127.731.5811.2
Pretax Income
582.9535.84498.33641.68871.89729.87
Income Tax Expense
107.583.2498.479.56124.49108.6
Earnings From Continuing Operations
475.4452.6399.92562.12747.4621.26
Minority Interest in Earnings
-10.23-2.96-2.740.972.01-1.94
Net Income
465.17449.64397.18563.08749.41619.33
Net Income to Common
465.17449.64397.18563.08749.41619.33
Net Income Growth
69.97%13.21%-29.46%-24.86%21.00%22.76%
Shares Outstanding (Basic)
996999993988989989
Shares Outstanding (Diluted)
996999993988989989
Shares Change
0.31%0.63%0.51%-0.13%0.00%7.84%
EPS (Basic)
0.470.450.400.570.760.63
EPS (Diluted)
0.470.450.400.570.760.63
EPS Growth
69.45%12.50%-29.83%-24.76%21.00%13.84%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
574.6338.4191.07360.85326.74409.31
Free Cash Flow Per Share
0.580.040.190.360.330.41
Dividend Per Share
0.3000.3000.3000.3000.3000.150
Dividend Growth
-25.00%0%0%0%100.00%0%
Gross Margin
59.81%60.18%56.40%52.18%57.42%57.58%
Operating Margin
11.74%11.41%15.43%14.67%15.50%15.44%
Profit Margin
12.05%11.96%9.93%13.66%17.11%14.21%
Free Cash Flow Margin
14.88%1.02%4.78%8.75%7.46%9.39%
EBITDA
662.89643.22837.73816.24866.26857.11
EBITDA Margin
17.16%17.11%20.94%19.79%19.78%19.67%
D&A For EBITDA
209.69214.24220.31211.45187.46184.19
EBIT
453.2428.98617.42604.79678.81672.92
EBIT Margin
11.74%11.41%15.43%14.67%15.50%15.44%
Effective Tax Rate
18.44%15.53%19.75%12.40%14.28%14.88%
Revenue as Reported
3,8623,7594,0014,1234,3804,357
Advertising Expenses
-860712.54685.06991.031,035